Abu Dhabi opens up free COVID-19 vaccines to tourists

A man receives a dose of a vaccine against the coronavirus disease (COVID-19) at St. Paul's Church in Abu Dhabi. (Reuters)
Short Url
Updated 22 June 2021
Follow

Abu Dhabi opens up free COVID-19 vaccines to tourists

  • Infections have risen in the UAE in the past month, and Abu Dhabi still has restrictions on entry, including home quarantine and PCR testing at intervals after arrival

DUBAI: Abu Dhabi, the capital of the United Arab Emirates, is offering tourists free COVID-19 vaccinations that were previously restricted to UAE citizens and residency visa holders.
There is no indication that the change applies to Dubai, the most populous emirate, or the other five emirates that make up the UAE.
Visitors with visas issued by Abu Dhabi and passport holders eligible for tourist visas when they arrive in the UAE through Abu Dhabi can book free vaccines, according to information provided by the Abu Dhabi Health Services Company (SEHA), which operates the emirate’s public health infrastructure.
Holders of expired residency or entry visas are also eligible for free vaccinations, Abu Dhabi Media Office said on June 11.
Job losses and travel restrictions during the pandemic mean some people’s residency visas have expired or have been canceled when they were made redundant.
UAE Health authorities said this month nearly 85 percent of the eligible population had received at least one vaccine dose, but did not say how many had had two doses.
Infections have risen in the UAE in the past month, and Abu Dhabi still has restrictions on entry, including home quarantine and PCR testing at intervals after arrival. People driving from other emirates are tested to show they are not infected.
Travelers from 27 countries including China, Germany and the United States can enter without quarantine on arrival.
SEHA offers COVID-19 vaccines by China’s state-owned drugmaker Sinopharm and by Pfizer/BioNTech in Abu Dhabi.
Dubai Media Office did not immediately respond to a request for comment on whether eligibility criteria was to change. Dubai Health Authority information says vaccines are given only to citizens and holders of valid Dubai residency visas.


Closing Bell: Saudi main index closes in red at 11,183

Updated 16 February 2026
Follow

Closing Bell: Saudi main index closes in red at 11,183

RIYADH: Saudi Arabia’s Tadawul All Share Index dipped on Monday, losing 44.79 points, or 0.4 percent, to close at 11,183.85.

The total trading turnover of the benchmark index was SR4.05 billion ($1.08 billion), as 69 of the listed stocks advanced, while 191 retreated.

The MSCI Tadawul Index decreased, down 6.63 points or 0.44 percent, to close at 1,504.73.

The Kingdom’s parallel market Nomu lost 328.20 points, or 1.36 percent, to close at 23,764.92. This comes as 22 of the listed stocks advanced, while 49 retreated.

The best-performing stock was Maharah Human Resources Co., with its share price surging by 7.26 percent to SR6.50.

Other top performers included Arabian Cement Co., which saw its share price rise by 6.27 percent to SR22.71, and Saudi Research and Media Group, which saw a 4.3 percent increase to SR104.30.

On the downside, the worst performer of the day was Arabian Internet and Communications Services Co., whose share price fell by 8.01 percent to SR207.80.

Jahez International Co. for Information System Technology and Al-Rajhi Co. for Cooperative Insurance also saw declines, with their shares dropping by 5.61 percent and 4.46 percent to SR12.79 and SR75, respectively.

On the announcement front, Etihad Etisalat Co. announced its financial results for 2025 with a 7.9 percent year-on-year growth in its revenues, to reach SR19.6 billion.

In a Tadawul statement, Mobily said that this growth is attributed to “the expansion of all revenue streams, with a healthy growth in the overall subscriber base.”

Mobily delivered an 11.6 percent increase in net profit, reaching SR3.4 billion in 2025 compared to SR3.1 billion in 2024.

The company’s share price reached SR67.85, marking a 0.37 percent increase on the main market.